ATLANTA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced it has won 22 Digital Health Awards in the Health Information Resource Center’s Fall 2023 competition. Celebrating its 25th anniversary this year, the Digital Health Awards honors the best online and virtual health resources for both consumers and professionals.
“We’re honored by these accolades for our innovative app-based programs, clinically validated solutions, and educational content, which deliver outstanding results across our clients’ member populations,” said Dawn Whaley, president and chief marketing officer at Sharecare. “Our data-driven approach has created millions of dollars in potential savings for some of the nation’s largest employers and health plans by providing resources to help people effectively navigate their healthcare and improve their well-being.”
Earning the top spot in four categories, Sharecare was honored for its efforts to engage, educate, and support people in managing their health more broadly through its social channels and content initiatives, including those that promote the advancement of health equity. Additionally, Sharecare was bestowed seven Digital Health Awards recognizing the depth, breadth, and quality of its flagship platform for comprehensive care solutions for large employers and health plans, as well as the content and tools within it, including its proprietary mental well-being program and digital therapeutics for diabetes prevention and weight loss, tobacco cessation, and anxiety.
The company’s full list of Fall 2023 Digital Health Awards are as follows:
Gold Awards
Silver Awards
Bronze Awards
Merit Awards
About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.
Media Contact:
Sharecare PR Team
This email address is being protected from spambots. You need JavaScript enabled to view it.
404.665.4305
| Last Trade: | US$1.43 |
| Daily Volume: | 0 |
| Market Cap: | US$531.790M |
September 10, 2024 August 09, 2024 March 28, 2024 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
